We are live on ! Find out more
AC

Athanor Capital Portfolio holdings

AUM $24.6M
1-Year Est. Return 2.49%
This Fund
S&P 500
This Quarter Est. Return
+43.66%
1 Year Est. Return
+2.49%
3 Year Est. Return
+171.12%
5 Year Est. Return
+304.82%
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$434M
Cap. Flow
+$4.26M
Cap. Flow %
0.22%
Top 10 Hldgs %
32.91%
Holding
599
New
439
Increased
45
Reduced
39
Closed
72

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.11%
2 Consumer Discretionary 19.35%
3 Technology 16.65%
4 Financials 12.68%
5 Communication Services 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNIT
401
Uniti Group
UNIT
$2.32B
$319K 0.02%
+34,066
New +$256K
PODD icon
402
Insulet
PODD
$9.75B
$318K 0.02%
+1,635
New +$313K
INTC icon
403
Intel
INTC
$534B
$316K 0.02%
+5,274
New +$315K
ZION icon
404
Zions Bancorporation
ZION
$9.56B
$314K 0.02%
+9,227
New +$292K
WYNN icon
405
Wynn Resorts
WYNN
$8.67B
$313K 0.02%
+4,199
New +$337K
STOK icon
406
Stoke Therapeutics
STOK
$1.8B
$311K 0.02%
+13,055
New +$310K
MTB icon
407
M&T Bank
MTB
$32.6B
$310K 0.02%
+2,984
New +$315K
RLMD icon
408
Relmada Therapeutics
RLMD
$450M
$309K 0.02%
+6,913
New +$292K
AAT
409
American Assets Trust
AAT
$1.34B
$305K 0.02%
+10,965
New +$300K
RPAI
410
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$305K 0.02%
+41,603
New +$240K
CRUS icon
411
Cirrus Logic
CRUS
$5.91B
$303K 0.02%
+4,901
New +$335K
EDU icon
412
New Oriental
EDU
$8.88B
$303K 0.02%
+2,324
New +$283K
STSA
413
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$303K 0.02%
+10,535
New +$244K
ANET icon
414
Arista Networks
ANET
$249B
$302K 0.02%
+23,008
New +$311K
NVRO
415
DELISTED
NEVRO CORP.
NVRO
$302K 0.02%
+2,527
New +$300K
CUE icon
416
Cue Biopharma
CUE
$248M
$299K 0.02%
+407
New +$295K
H icon
417
Hyatt Hotels
H
$15B
$298K 0.02%
+5,920
New +$315K
PBH icon
418
Prestige Consumer Healthcare
PBH
$2.22B
$295K 0.02%
+7,855
New +$314K
EXPO icon
419
Exponent
EXPO
$3.23B
$289K 0.01%
+3,568
New +$257K
PRVL
420
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$288K 0.01%
+19,347
New +$298K
CRNX
421
DELISTED
Crinetics Pharmaceuticals
CRNX
$287K 0.01%
+16,364
New +$279K
HR
422
DELISTED
Healthcare Realty Trust Incorporated
HR
$287K 0.01%
+9,800
New +$293K
KEX icon
423
Kirby Corp
KEX
$7.23B
$286K 0.01%
+5,331
New +$272K
FTDR icon
424
Frontdoor
FTDR
$5.55B
$281K 0.01%
+6,333
New +$258K
VSTO
425
DELISTED
Vista Outdoor Inc.
VSTO
$278K 0.01%
+19,266
New +$193K

Similar funds

Athanor Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Athanor Capital held 599 positions worth $1.97B, up 28% from $1.54B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Athanor Capital's Q2 2020 filing shows 439 new, 45 increased, 39 reduced and 72 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 522,500 shares worth $57.1M. The largest sale was SPDR Gold Trust, an estimated $72.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Athanor Capital's largest Q2 2020 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 522,500 shares worth $57.1M.
  • Athanor Capital added most to NextEra Energy in Q2 2020, an estimated $28.2M increase.
  • Athanor Capital's biggest Q2 2020 reduction was AGNC Investment, cutting an estimated $67.6M.
  • Athanor Capital fully exited SPDR Gold Trust in Q2 2020, selling an estimated $72.9M.
  • Athanor Capital's ten largest holdings make up 33% of its $1.97B portfolio in Q2 2020.
  • Athanor Capital opened 439 new positions and closed 72 in Q2 2020.
  • Athanor Capital's portfolio value rose 28% quarter-over-quarter to $1.97B.

Based on Athanor Capital's 13F filing for Q2 2020, filed 13 Aug 2020.